: We find that the SH2-containing Inositol Phosphatase (SHIP) plays a crucial role in defining the inhibitory repertoire of NK cells in vivo. Four key findings made by our group support this hypothesis: (1) SHIP is recruited to both Ly49A and Ly49C in vivo, (2) the 85kD regulatory subunit of P1-3-Kinase (P13K) is recruited to Ly49A in vivo, (3) Akt is constitutively active in SHIP-/- NK cells in vivo and (4) a subset of NK cells that co express Ly49A and Ly49C dominates the adult NK compartment in SHIP-/- mice. Ly49A and Ly49C can interact with self MHC ligands in our SHIP-/- mice, but also ligands of other MHC haplotypes. This promiscuous NK inhibitory repertoire has profound functional consequences as SHIP-/- mice fail to reject fully histo-incompatible marrow grafts. Strikingly, we find that survival of SHIP-/- mice is dramatically enhanced relative to wild-type littermates following transplantation of fully histo-incompatible marrow. These findings demonstrate a critical role for SHIP in two processes that limit the success of histo-incompatible marrow transplantation: graft rejection and graft-vs.-host disease. We now propose to confirm and extend our initial observations to gain a better understanding of how SHIP shapes the NK cell inhibitory repertoire and to better understand how this impacts marrow transplantation across major histocompatibility barriers. Specifically we will: (1) Determine the mechanism by which SHIP influences the NK inhibitory repertoire, (2) Determine whether a """"""""self-restricted"""""""" NK inhibitory repertoire alters the ability of NK cells to respond to activating receptors and (3) Determine the mechanism for failure of graft rejection and abrogated GVHD during allogeneic BMT in SH1P-/- mice.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL072523-02
Application #
6603569
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Thomas, John
Project Start
2002-07-01
Project End
2006-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
2
Fiscal Year
2003
Total Cost
$290,000
Indirect Cost
Name
University of South Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
069687242
City
Tampa
State
FL
Country
United States
Zip Code
33612
Fernandes, Sandra; Srivastava, Neetu; Sudan, Raki et al. (2018) SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn's Disease and Peripheral T Cell Reduction. Front Immunol 9:1100
Somasundaram, Rajesh; Fernandes, Sandra; Deuring, Jasper J et al. (2017) Analysis of SHIP1 expression and activity in Crohn's disease patients. PLoS One 12:e0182308
Park, Mi Young; Sudan, Raki; Srivastava, Neetu et al. (2016) LRBA is Essential for Allogeneic Responses in Bone Marrow Transplantation. Sci Rep 6:36568
Srivastava, Neetu; Iyer, Sonia; Sudan, Raki et al. (2016) A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndrome. JCI Insight 1:
Lind, Evan F; Millar, Douglas G; Dissanayake, Dilan et al. (2015) miR-155 Upregulation in Dendritic Cells Is Sufficient To Break Tolerance In Vivo by Negatively Regulating SHIP1. J Immunol 195:4632-40
Anderson, Courtney K; Salter, Alexander I; Toussaint, Leon E et al. (2015) Role of SHIP1 in Invariant NKT Cell Development and Functions. J Immunol 195:2149-2156
Iyer, Sonia; Brooks, Robert; Gumbleton, Matthew et al. (2015) SHIP1-expressing mesenchymal stem cells regulate hematopoietic stem cell homeostasis and lineage commitment during aging. Stem Cells Dev 24:1073-81
Blanco-Menéndez, Noelia; Del Fresno, Carlos; Fernandes, Sandra et al. (2015) SHIP-1 Couples to the Dectin-1 hemITAM and Selectively Modulates Reactive Oxygen Species Production in Dendritic Cells in Response to Candida albicans. J Immunol 195:4466-4478
Brooks, R; Iyer, S; Akada, H et al. (2015) Coordinate expansion of murine hematopoietic and mesenchymal stem cell compartments by SHIPi. Stem Cells 33:848-58
Fernandes, Sandra; Brooks, Robert; Gumbleton, Matthew et al. (2015) SHIPi Enhances Autologous and Allogeneic Hematolymphoid Stem Cell Transplantation. EBioMedicine 2:205-213

Showing the most recent 10 out of 44 publications